# Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes

> **NCT00596817** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 639 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Placebo
- **DRUG:** Vortioxetine (Lu AA21004)

## Key facts

- **NCT ID:** NCT00596817
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2009-09
- **Final completion:** 2009-10
- **Target enrollment:** 639 (ACTUAL)
- **Last updated:** 2014-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00596817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00596817, "Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00596817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*